Mariëlle Kloosterman1, Jonas Oldgren2, David Conen3, Jorge A Wong3, Stuart J Connolly3, Alvaro Avezum4, Salim Yusuf3, Michael D Ezekowitz5, Lars Wallentin2, Marie Ntep-Gweth6, Philip Joseph3, Tyler W Barrett7, Supachai Tanosmsup8, William F McIntyre3, Shun Fu Lee3, Ratika Parkash9, Guy Amit3, Alex Grinvalds3, Isabelle C Van Gelder1, Jeff S Healey3. 1. Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 2. Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. 3. Population Health Research Institute, Department of Medicine, McMaster University, 30 Birge St. Room C3-121, Hamilton, Ontario L8L 0A6, Canada. 4. Division of Cardiology, Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil. 5. Department of Medicine, Medical College and Lankenau Medical Center, Wynnewood, PA, USA. 6. Department of Medicine, Hôpital Central de Yaoundé, Yaounde, Cameroon. 7. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. 8. Department of Medicine, Mahidol University, Bangkok, Thailand. 9. Department of Medicine, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
Abstract
AIMS: Data on patient characteristics, prevalence, and outcomes of atrial fibrillation (AF) patients without traditional risk factors, often labelled 'lone AF', are sparse. METHODS AND RESULTS: The RE-LY AF registry included 15 400 individuals who presented to emergency departments with AF in 47 countries. This analysis focused on patients without traditional risk factors, including age ≥60 years, hypertension, coronary artery disease, heart failure, left ventricular hypertrophy, congenital heart disease, pulmonary disease, valve heart disease, hyperthyroidism, and prior cardiac surgery. Patients without traditional risk factors were compared with age- and region-matched controls with traditional risk factors (1:3 fashion). In 796 (5%) patients, no traditional risk factors were present. However, 98% (779/796) had less-established or borderline risk factors, including borderline hypertension (130-140/80-90 mmHg; 47%), chronic kidney disease (eGFR < 60 mL/min; 57%), obesity (body mass index > 30; 19%), diabetes (5%), excessive alcohol intake (>14 units/week; 4%), and smoking (25%). Compared with patients with traditional risk factors (n = 2388), patients without traditional risk factors were more often men (74% vs. 59%, P < 0.001) had paroxysmal AF (55% vs. 37%, P < 0.001) and less AF persistence after 1 year (21% vs. 49%, P < 0.001). Furthermore, 1-year stroke occurrence rate (0.6% vs. 2.0%, P = 0.013) and heart failure hospitalizations (0.9% vs. 12.5%, P < 0.001) were lower. However, risk of AF-related re-hospitalization was similar (18% vs. 21%, P = 0.09). CONCLUSION: Almost all patients without traditionally defined AF risk factors have less-established or borderline risk factors. These patients have a favourable 1-year prognosis, but risk of AF-related re-hospitalization remains high. Greater emphasis should be placed on recognition and management of less-established or borderline risk factors. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Data on patient characteristics, prevalence, and outcomes of atrial fibrillation (AF) patients without traditional risk factors, often labelled 'lone AF', are sparse. METHODS AND RESULTS: The RE-LY AF registry included 15 400 individuals who presented to emergency departments with AF in 47 countries. This analysis focused on patients without traditional risk factors, including age ≥60 years, hypertension, coronary artery disease, heart failure, left ventricular hypertrophy, congenital heart disease, pulmonary disease, valve heart disease, hyperthyroidism, and prior cardiac surgery. Patients without traditional risk factors were compared with age- and region-matched controls with traditional risk factors (1:3 fashion). In 796 (5%) patients, no traditional risk factors were present. However, 98% (779/796) had less-established or borderline risk factors, including borderline hypertension (130-140/80-90 mmHg; 47%), chronic kidney disease (eGFR < 60 mL/min; 57%), obesity (body mass index > 30; 19%), diabetes (5%), excessive alcohol intake (>14 units/week; 4%), and smoking (25%). Compared with patients with traditional risk factors (n = 2388), patients without traditional risk factors were more often men (74% vs. 59%, P < 0.001) had paroxysmal AF (55% vs. 37%, P < 0.001) and less AF persistence after 1 year (21% vs. 49%, P < 0.001). Furthermore, 1-year stroke occurrence rate (0.6% vs. 2.0%, P = 0.013) and heart failure hospitalizations (0.9% vs. 12.5%, P < 0.001) were lower. However, risk of AF-related re-hospitalization was similar (18% vs. 21%, P = 0.09). CONCLUSION: Almost all patients without traditionally defined AF risk factors have less-established or borderline risk factors. These patients have a favourable 1-year prognosis, but risk of AF-related re-hospitalization remains high. Greater emphasis should be placed on recognition and management of less-established or borderline risk factors. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Michiel Rienstra; Anne H Hobbelt; Marco Alings; Jan G P Tijssen; Marcelle D Smit; Johan Brügemann; Bastiaan Geelhoed; Robert G Tieleman; Hans L Hillege; Raymond Tukkie; Dirk J Van Veldhuisen; Harry J G M Crijns; Isabelle C Van Gelder Journal: Eur Heart J Date: 2018-08-21 Impact factor: 29.983
Authors: Michiel Rienstra; Isabelle C Van Gelder; Vincent E Hagens; Nic J G M Veeger; Dirk J Van Veldhuisen; Harry J G M Crijns Journal: Eur Heart J Date: 2005-11-07 Impact factor: 29.983
Authors: B Weijs; C B de Vos; R G Tieleman; F E C M Peeters; I Limantoro; A A Kroon; E C Cheriex; R Pisters; H J G M Crijns Journal: Europace Date: 2012-07-10 Impact factor: 5.214
Authors: S L Kopecky; B J Gersh; M D McGoon; J P Whisnant; D R Holmes; D M Ilstrup; R L Frye Journal: N Engl J Med Date: 1987-09-10 Impact factor: 91.245
Authors: Jonas Oldgren; Jeff S Healey; Michael Ezekowitz; Patrick Commerford; Alvaro Avezum; Prem Pais; Jun Zhu; Petr Jansky; Alben Sigamani; Carlos A Morillo; Lisheng Liu; Albertino Damasceno; Alex Grinvalds; Juliet Nakamya; Paul A Reilly; Katalin Keltai; Isabelle C Van Gelder; Afzal Hussein Yusufali; Eiichi Watanabe; Lars Wallentin; Stuart J Connolly; Salim Yusuf Journal: Circulation Date: 2014-01-24 Impact factor: 29.690
Authors: D George Wyse; Isabelle C Van Gelder; Patrick T Ellinor; Alan S Go; Jonathan M Kalman; Sanjiv M Narayan; Stanley Nattel; Ulrich Schotten; Michiel Rienstra Journal: J Am Coll Cardiol Date: 2014-02-12 Impact factor: 24.094
Authors: Arshad Jahangir; Victor Lee; Paul A Friedman; Jane M Trusty; David O Hodge; Stephen L Kopecky; Douglas L Packer; Stephen C Hammill; Win-Kuang Shen; Bernard J Gersh Journal: Circulation Date: 2007-06-04 Impact factor: 29.690
Authors: Wern Yew Ding; Nikola Kozhuharov; Shui Hao Chin; Matthew Shaw; Richard Snowdon; Gregory Y H Lip; Dhiraj Gupta Journal: J Arrhythm Date: 2020-09-13